This Article Free upon publication Full Text Full Text (PDF) CME: Take the course for this article: Circulation: February 17, 2009, Volume 119, Number 6 All Versions of this Article: 119/6/797    most recent CIRCULATIONAHA.108.802314v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kang, D.-H. Articles by Lee, J.-W. Search for Related Content PubMed PubMed Citation Articles by Kang, D.-H. Articles by Lee, J.-W. Related Collections CV surgery: valvular disease Related Article

(Circulation. 2009;119:797-804.)
© 2009 American Heart Association, Inc.

Cardiovascular Surgery

Comparison of Early Surgery Versus Conventional Treatment in Asymptomatic Severe Mitral Regurgitation

Duk-Hyun Kang, MD, PhD; Jeong Hoon Kim, MD; Ji Hye Rim, MD; Mi-Jeong Kim, MD; Sung-Cheol Yun, PhD; Jong-Min Song, MD, PhD; Hyun Song, MD, PhD; Kee-Joon Choi, MD, PhD; Jae-Kwan Song, MD, PhD; Jae-Won Lee, MD, PhD

From the Division of Cardiology, Cardiac Surgery, Biostatistics, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea.

Correspondence to Duk-Hyun Kang, MD, PhD, Professor of Medicine, Division of Cardiology, Asan Medical Center, College of Medicine, University of Ulsan, 388-1, Poongnap-dong, Songpa-ku, Seoul, Korea 138-736. E-mail dhkang{at}amc.seoul.kr

Received November 29, 2007; accepted October 30, 2008.

Background— The optimal timing of surgical intervention in asymptomatic patients with severe mitral regurgitation is unclear. We therefore compared the long-term results of early surgery with a conventional treatment strategy.

Methods and Results— From 1996 to 2005, 447 consecutive asymptomatic patients (253 men, age 50±15 years) with severe degenerative mitral regurgitation and preserved left ventricular function were evaluated prospectively. The end point was defined as the composite of operative mortality, cardiac death, repeat mitral valve surgery, and urgent admission due to congestive heart failure during follow-up. Early surgery was performed on 161 patients (operated group), and the conventional treatment strategy was used for 286 patients (conventional treatment group). There were no significant differences between the 2 groups in terms of age, gender, euroSCORE (European System for Cardiac Operative Risk Evaluation), or ejection fraction. During a median follow-up of 1988 days, there were 2 repeat surgeries and no cardiac deaths or operative mortality in the operated group compared with 12 cardiac deaths, 1 repeat surgery, and 22 admissions for congestive heart failure in the conventional treatment group. The estimated actuarial 7-year cardiac mortality rate was 0% in the operated group and 5±2% in the conventional treatment group (P=0.008), and for 127 propensity score-matched pairs, the estimated actuarial 7-year event-free survival rate was significantly higher in the operated than in the conventional treatment group (99±1% versus 85±4%, P=0.007). In the conventional treatment group, baseline grade of pulmonary hypertension (hazard ratio 1.87, 95% CI 1.22 to 2.87, P=0.003), age (hazard ratio 1.02, 95% CI 1.01 to 1.04, P=0.005), and effective regurgitant orifice area (hazard ratio 2.06, 95% CI 1.11 to 3.82, P=0.02) were independent variables that predicted late development of surgical indications or congestive heart failure on Cox multivariate analysis.

Conclusions— Compared with conservative management, the strategy of early surgery was associated with an improved long-term event rate by decreasing cardiac mortality and congestive heart failure hospitalization more effectively in patients with severe degenerative mitral regurgitation. Early surgery may therefore further improve clinical outcomes in asymptomatic severe mitral regurgitation with preserved left ventricular systolic function and a high likelihood of mitral valve repair.

---

 

CLINICAL PERSPECTIVE

Related Article:

Clinical Summaries
Circulation 2009 119: 765-767. [Extract] [Full Text]

This article has been cited by other articles:

				E. Picano, P. Pibarot, P. Lancellotti, J. L. Monin, and R. O. Bonow The Emerging Role of Exercise Testing and Stress Echocardiography in Valvular Heart Disease J. Am. Coll. Cardiol., December 8, 2009; 54(24): 2251 - 2260. [Abstract] [Full Text] [PDF]

				S. Verma and T. G. Mesana Mitral-Valve Repair for Mitral-Valve Prolapse N. Engl. J. Med., December 3, 2009; 361(23): 2261 - 2269. [Full Text] [PDF]

				P. A. McCullough and G. S. Hanzel B-type natriuretic peptide and echocardiography in the surveillance of severe mitral regurgitation prior to valve surgery. J. Am. Coll. Cardiol., September 15, 2009; 54(12): 1107 - 1109. [Full Text] [PDF]

				Early Surgery Beneficial for Asymptomatic Severe Mitral Regurgitation Journal Watch Cardiology, March 18, 2009; 2009(318): 4 - 4. [Full Text]